Innate Pharma
IPHA
#8777
Rank
NZ$0.26 B
Marketcap
NZ$2.84
Share price
-1.16%
Change (1 day)
-19.38%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2024: -NZ$85.54 Million

According to Innate Pharma 's latest financial reports the company's current earnings are NZ$13.13 Million. In 2024 the company made an earning of -NZ$85.54 Million a decrease over its 2023 earnings that were of -NZ$13.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2024

Annual earnings

Year Earnings Change
2024-NZ$85.54 Million515.18%
2023-NZ$13.91 Million-86.54%
2022-NZ$0.11 Billion20.74%
2021-NZ$85.58 Million4951.08%
2020-NZ$1.7 Million-111.57%
2019NZ$14.64 M183.46%
2018NZ$5.16 M-105.4%
2017-NZ$95.73 Million-523.25%
2016NZ$22.61 M-285.64%
2015-NZ$12.19 Million-69.31%
2014-NZ$39.71 Million498.29%
2013-NZ$6.64 Million-5.62%
2012-NZ$7.04 Million-53.32%
2011-NZ$15.07 Million-50.1%
2010-NZ$30.19 Million-13.3%
2009-NZ$34.82 Million26.36%
2008-NZ$27.56 Million27.35%
2007-NZ$21.64 Million63.33%
2006-NZ$13.25 Million9.81%
2005-NZ$12.07 Million